⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15185115 | 0.82 | — | — | |
| SCHEMBL15423551 | 0.82 | — | — | |
| SCHEMBL13569656 | 0.80 | — | — | |
| SCHEMBL10646299 | 0.80 | TRPA1 (0.30) | — | |
| SCHEMBL11365551 | 0.79 | EPHX2 (0.36) | — | |
| SCHEMBL3688783 | 0.78 | LMNA (0.38) | — | |
| SCHEMBL4889810 | 0.78 | ESR2 (0.32) | — | |
| SCHEMBL25708575 | 0.78 | CNR2 (0.34) | — | |
| SCHEMBL11983881 | 0.77 | — | — | |
| SCHEMBL15986025 | 0.76 | FUCA1 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024189618-A1 | FORMULAS FOR MASKING HUMAN SWEAT MALODOR | MOODIFY LTD (IL) | 2024-09-19 | — | — | WO | claimed |
| US-20030089885-A1 | Use of low molecular weight acetal, alcohol, acylated alcohol and ester compounds to block or reduce odor of carboxylic acids | SENOMYX, INC. | 2003-05-15 | — | — | US | claimed |
| WO-2002085294-A2 | USE OF LOW MOLECULAR WEIGHT ACETAL, ALCOHOL, ACYLATED ALCOHOL AND ESTER COMPOUNDS TO BLOCK OR REDUCE ODOR OF CARBOXYLIC ACIDS | SENOMYX, INC. (US) | 2002-10-31 | — | — | WO | claimed |
| US-12391802-B2 | Method of forming semicrystalline polyetherimide, and polyetherimide-containing composition | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2025-08-19 | — | — | US | disclosed |
| WO-2024189618-A1 | FORMULAS FOR MASKING HUMAN SWEAT MALODOR | MOODIFY LTD (IL) | 2024-09-19 | — | — | WO | disclosed |
| EP-4114177-A1 | COMPOSITIONS AND SYSTEMS FOR DISINFECTION | Markesbery Blue Pearl LLC (US) | 2023-01-11 | — | — | EP | disclosed |
| CN-113748155-B | Methods of forming semi-crystalline polyetherimides and compositions comprising polyetherimides | 高新特殊工程塑料全球技术有限公司 | 2022-07-22 | — | — | CN | disclosed |
| US-20220162387-A1 | METHOD OF FORMING SEMICRYSTALLINE POLYETHERIMIDE, AND POLYETHERIMIDECONTAINING COMPOSITION | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2022-05-26 | — | — | US | disclosed |
| CN-113748155-A | Methods of forming semi-crystalline polyetherimides and compositions comprising polyetherimides | 高新特殊工程塑料全球技术有限公司 | 2021-12-03 | — | — | CN | disclosed |
| WO-2021178774-A1 | COMPOSITIONS AND SYSTEMS FOR DISINFECTION | PANCHERI EUGENE J (US) | 2021-09-10 | — | — | WO | disclosed |
| WO-2020234683-A1 | METHOD OF FORMING SEMICRYSTALLINE POLYETHERIMIDE, AND POLYETHERIMIDE-CONTAINING COMPOSITION | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2020-11-26 | — | — | WO | disclosed |
| CN-102812037-A | Macrocyclic Ghrelin Receptor Antagonists And Inverse Agonists And Methods Of Using The Same | TRANZYME PHARMA INC | 2012-12-05 | — | — | CN | disclosed |
| US-20110105389-A1 | Macrocyclic Ghrelin Receptor Antagonists and Inverse Agonists and Methods of Using the Same | OCERA THERAPEUTICS, INC. | 2011-05-05 | — | — | US | disclosed |
| US-20110105389-A1 | Macrocyclic Ghrelin Receptor Antagonists and Inverse Agonists and Methods of Using the Same | OCERA THERAPEUTICS, INC. | 2011-05-05 | — | — | US | disclosed |
| WO-2011053821-A1 | MACROCYCLIC GHRELIN RECEPTOR ANTAGONISTS AND INVERSE AGONISTS AND METHODS OF USING THE SAME | TRANZYME PHARMA, INC. (US) | 2011-05-05 | — | — | WO | disclosed |
| US-20110105389-A1 | Macrocyclic Ghrelin Receptor Antagonists and Inverse Agonists and Methods of Using the Same | OCERA THERAPEUTICS, INC. | 2011-05-05 | — | — | US | disclosed |
| US-20030089885-A1 | Use of low molecular weight acetal, alcohol, acylated alcohol and ester compounds to block or reduce odor of carboxylic acids | SENOMYX, INC. | 2003-05-15 | — | — | US | disclosed |
| US-6503898-B1 | Administering 4,7-dibenzyl-5,6-dihydroxy-N,N*-di(m-aminobenzyl)--1,3-diazepin-2-one or salt to treat human immunodeficiency virus infection | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2003-01-07 | — | — | US | disclosed |
| WO-2002085294-A2 | USE OF LOW MOLECULAR WEIGHT ACETAL, ALCOHOL, ACYLATED ALCOHOL AND ESTER COMPOUNDS TO BLOCK OR REDUCE ODOR OF CARBOXYLIC ACIDS | SENOMYX, INC. (US) | 2002-10-31 | — | — | WO | disclosed |
| WO-1992004339-A1 | NOVEL PROSTAGLANDIN I2 DERIVATIVES | ASAHI GLASS COMPANY LTD. (JP) | 1992-03-19 | — | — | WO | disclosed |